宁波泰斯拓生物

www.testobio.com
  • 本公司产品仅供体外研究使用,不用于临床诊断
首页  /  产品中心  /  进口菌株

产品中心

试剂盒
菌株
质粒
试剂
联系我们  CONTACT US

0574-87917803

testobio@163.com

浙江省宁波市镇海区庄市街道兴庄路9号创e慧谷42号楼B幢401室
最新促销

货号: TS263591

名称: Candida metapsilosis


货号: TS263592

名称: Candida sake


货号: TS131909

名称: HFBCI28


货号: TS131910

名称: Septoria passiflorae Sydow, anamorph


货号: TS131911

名称: Graphium cuneiferum (Berkeley et Broome) Mason et Ellis


货号: TS131912

名称: Streptomyces scabiei (Thaxter) Lambert and Loria


货号: TSTOA0001

名称: Marisediminicola antarctica


货号: TS276951

名称: Real Time PCR EasyTM-Taqman


货号: TS276952

名称: Bacillus subtilis


货号: TS276954

名称: Bacillus subtilis

HCC1937 BL

货号 TS212057
中文名称 null
适应种属
检测范围
微信小陈 微信小章
在线留言
产品简介
购买须知
产品名称: HCC1937 BL
商品货号: TS212057
Organism: Homo sapiens, human
Tissue: peripheral blood
Cell Type: B lymphoblast; Epstein-Barr virus (EBV) transformed
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension, multicell aggregates
Biosafety Level: 2 Cells contain Epstein Barr Virus (EBV)

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: normal
Age: 24 years
Gender: female
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Derivation:
HCC1937BL is a B lymphoblastoid cell line initiated by Epstein-Barr virus (EBV) transformation of peripheral blood lymphocytes obtained from the same patient as HCC1937 (a primary breast ductal carcinoma cell line, ATCC CRL-2336).
Oncogene: BRCA1 (mutated, insertion C at nucleotide 5382)
Comments:
BRCA1 analysis revealed that this cell line is heterozygous for the BRCA1 5382C mutation, whereas the primary tumor cell line is homozygous for the same mutation.
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
Subculturing:
Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension in fresh medium at 3 to 5 x 105 viable cells/mL. Maintain cultures at cell concentrations between 5 x 105 and 2 x 106 viable cells/mL.
Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density).
Cryopreservation:
Complete growth medium 95%; DMSO, 5%. Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
Culture Conditions:
Temperature: 37°C
Atmosphere: Air, 95%; Carbon dioxide (CO2), 5%
Name of Depositor: AF Gazdar, AK Virmani
References:

Tomlinson GE, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation. Cancer Res. 58: 3237-3242, 1998. PubMed: 9699648

Gazdar AF, et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78: 766-774, 1998. PubMed: 9833771

Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.

Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.

Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.